Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. (Q51930932)

17 April 2018

title

Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. (English)

1 reference

17 April 2018

author

Irini Doytchinova

series ordinal

1

1 reference

17 April 2018

author name string

Darren R Flower

series ordinal

2

1 reference

17 April 2018

language of work or name

English

0 references

publication date

28 September 2006

1 reference

17 April 2018

published in

Vaccine

1 reference

17 April 2018

volume

25

1 reference

17 April 2018

issue

5

1 reference

17 April 2018

page(s)

856-866

1 reference

17 April 2018

Reverse vaccinology, a genome-based approach to vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Basic local alignment search tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Rapid and sensitive protein similarity searches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Expert system for predicting protein localization sites in gram-negative bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Improved prediction of signal peptides: SignalP 3.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Classification of G-protein coupled receptors by alignment-independent extraction of principal chemical properties of primary amino acid sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

The immunogenicity of single and combination DNA vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Identification of group B streptococcal Sip protein, which elicits cross-protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

TB subunit vaccines--putting the pieces together

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Peptide quantitative structure-activity relationships, a multivariate approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

The use of the area under the ROC curve in the evaluation of machine learning algorithms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Antibody-antigen interactions: contact analysis and binding site topography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Structure, function and properties of antibody binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Conformations of immunoglobulin hypervariable regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Modeling the Peptide−T Cell Receptor Interaction by the Comparative Molecular Similarity Indices Analysis−Soft Independent Modeling of Class Analogy Technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

Catalase, a novel antigen for Helicobacter pylori vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

7 January 2021

Human and guinea pig immune responses to Legionella pneumophila protein antigens OmpS and Hsp60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

7 January 2021

Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

7 January 2021

Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.032

7 January 2021

10.1016/J.VACCINE.2006.09.032

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018